Analyst Price Targets — PIII
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 15, 2026 12:43 pm | — | UBS | $14.00 | $7.75 | TheFly | P3 Health Partners price target raised to $14 from $4 at Lake Street |
| March 27, 2026 12:54 pm | Ben Haynor | Lake Street | $4.00 | $2.94 | TheFly | P3 Health Partners price target lowered to $4 from $12.50 at Lake Street |
| November 17, 2025 1:50 pm | — | Lake Street | $12.50 | $6.36 | TheFly | P3 Health Partners price target lowered to $12.50 from $20 at Lake Street |
| August 28, 2025 11:22 am | — | Lake Street | $20.00 | $8.32 | TheFly | P3 Health Partners assumed with a Buy at Lake Street |
Latest News for PIII
President Trump's 12-word remark, “I don't think about Americans' financial situation, I don't think about anybody,” hit the wires, and the reaction showed up in the forgotten corners of the market, where micro-cap turnarounds priced like option contracts ripped higher on May 15 as traders rotated into beaten-down names with operational catalysts already in motion.
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2026. "Q1 represents a meaningful turning point for the business. The $26 million of adjusted EBITDA we delivered this quarter reflects the cumulative impact of two years…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PIII.
U.S. House Trading
No House trades found for PIII.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.